Version history

{
  "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7_task_73907230",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "scidex.core.llm.complete",
  "action": "propose",
  "content": "# Therapeutic Hypotheses: Coordination of Organelle-Specific Autophagy in Neurodegeneration\n\n---\n\n## Hypothesis 1: Mitochondrial-ER Contact Sites as Coordination Hubs\n\n**Title:** MFN2-PACS2 axis as a \"mitophagy-ER-phagy sync switch\" via MAM reorganization\n\n**Mechanism:** MFN2 anchors mitochondria to ER at MAMs; upon mitochondrial stress, MFN2 mediates contact site remodeling that simultaneously positions mitophagy receptors (e.g., NDP52) near ER-sourced membranes while PACS2-regulated ER calcium microdomains trigger both organelle-specific autophagosome nucleation. Disrupting this axis collapses coordinated quality control.\n\n**Target gene/protein/pathway:** MFN2 (mitochondrial fusion) + PACS2 (ER phosphoregulation); crosstalk via calcium/PI(4,5)P2 signaling at MAMs.\n\n**Supporting evidence with PMIDs:**\n- MFN2 physically interacts with LC3 via LIR motif; MFN2 knockdown impairs mitophagy (PMID: 31171695)\n- PACS2 regulates ER-mitochondria tethering and calcium homeostasis (PMID: 25437556)\n- MAM integrity is compromised in ALS/PD patient neurons (PMID: 31641032)\n- ER contribute membranes to autophagosomes via WIPI2/PI3KC3 during selective autophagy (PMID: 25648100)\n\n**Predicted experiment:** CRISPRi screen targeting MAM proteins in iPSC-derived neurons; measure synchronized mitophagy (mt-Keima) + reticulophagy (RFP-LC3 + KDEL retention) reporters. Expect double-knockdown of MFN2+PACS2 to produce >80% synergistic defect vs. single knockdowns.\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 2: TFEB/TFE3 Parallel Activation as Master Coordinator\n\n**Title:** Simultaneous TFEB+TFE3 activation drives coordinated organelle clearance via CLEAR-box divergence\n\n**Mechanism:** TFEB/TFE3 translocate to nucleus under mTORC1 inhibition or AMPK activation, binding CLEAR sequences in promoters of both shared (BECN1, GABARAP) and organelle-specific (PRKN/parkin, RETREG1/ FAM134B) genes. TFE3 preferentially drives ER-phagy gene programs; TFEB drives mitophagy genes, but both heterodimerize to co-regulate lysosomal biogenesis, creating a feedforward loop that simultaneously clears multiple damaged organelles.\n\n**Target gene/protein/pathway:** TFEB/TFE3 nuclear translocation; upstream: mTORC1 (MTOR), LKB1/STK11-AMPK axis; downstream CLEAR network.\n\n**Supporting evidence with PMIDs:**\n- TFEB/TFE3 double KO in neurons causes severe neurodegeneration (PMID: 31801954)\n- TFEB overexpression rescues mitochondrial and ER stress in PD models (PMID: 29311652)\n- TFE3 drives reticulophagy via ER stress response (PMID: 29045917)\n- CLEAR network encompasses >400 autophagy-lysosome genes (PMID: 26942069)\n- TFE3 can compensate for TFEB loss in some contexts (PMID: 31501761)\n\n**Predicted experiment:** Use dCas9-SAM system to simultaneously activate TFEB and TFE3 in primary neurons; perform multi-organelle proteomics (mitochondria ER lysosome fractions) over 72h and compare to single activation. Expect additive/superadditive clearance of mitochondrial (TOMM20), ER (CLIMP63), and lysosomal (LAMP1) proteins.\n\n**Confidence:** 0.78\n\n---\n\n## Hypothesis 3: TBK1-OPTN-NDP52 Phospho-Cascade as Organelle-Spanning Autophagy Hub\n\n**Title:** TBK1-mediated phosphorylation of multiple cargo receptors coordinates organelle turnover\n\n**Mechanism:** TBK1 phosphorylates OPTN (Ser177) and NDP52 (Ser67) on ubiquitin-binding domains, enhancing affinity for ubiquitin-coated damaged organelles. OPTN primarily targets mitochondria; NDP52 can engage both mitochondria and Salmonella, but also ER-derived vesicles. TBK1 thus \"broadcasts\" autophagy investment to multiple organelles simultaneously; familial ALS mutations in TBK1 (loss-of-function) impair this multi-organelle response.\n\n**Target gene/protein/pathway:** TBK1 (kinase); OPTN (cargo receptor); NDP52/CALCOCO2 (cargo receptor).\n\n**Supporting evidence with PMIDs:**\n- TBK1 phosphorylates OPTN Ser177, enhancing mitophagy (PMID: 24592263)\n- NDP52 recruits autophagy machinery to damaged mitochondria independently of parkin (PMID: 25985789)\n- TBK1 mutations cause ALS with impaired mitophagy (PMID: 24951150)\n- OPTN also mediates ER-phagy under starvation (PMID: 32048902)\n- TBK1 activity required for general selective autophagy (PMID: 25556504)\n\n**Predicted experiment:** Generate phospho-deficient OPTN (S177A) and NDP52 (S67A) iPSC lines via CRISPR; measure mitophagy and reticulophagy flux using dual-reporter system (mito-QC + ER-phyto). Expect that phospho-mutant receptors impair both processes while phospho-mimetic rescue restores coordination. Validate in TBK1 KO background.\n\n**Confidence:** 0.81\n\n---\n\n## Hypothesis 4: p62 Phase Separation as Organelle-Agnostic Sequestration Platform\n\n**Title:** p62 liquid-liquid phase separation nucleates cross-organelle protein aggregates for coordinated autophagy\n\n**Mechanism:** p62 undergoes liquid-liquid phase separation (LLPS) upon phosphorylation (Ser403) and ubiquitination of bound cargo. p62 droplets can concentrate ubiquitinated proteins from multiple organelles (damaged mitochondria, ER fragments, protein aggregates) into a single autophagosomal capture event. This \"mixed garbage collection\" allows one phagophore to engulf multi-organelle cargo. Phosphorylated p62 also activates NRF2, providing transcriptional feedback.\n\n**Target gene/protein/pathway:** SQSTM1/p62 (scaffold); ULK1/FIP200 (phosphorylation at Ser403); Keap1 (NRF2 pathway).\n\n**Supporting evidence with PMIDs:**\n- p62 LLPS required for selective autophagy (PMID: 31439799, 31801953)\n- p62 phosphorylated at Ser403 by casein kinase 2/TBK1 enhances aggregate clearance (PMID: 23842799)\n- p62 body formation captures both mitochondria and ER in neuroprotection (PMID: 31506447)\n- Keap1-p62 axis links autophagy to NRF2 antioxidant response (PMID: 27459026)\n- p62 deletion causes mitochondrial and ER dysfunction in mice (PMID: 30626971)\n\n**Predicted experiment:** Express p62 or phospho-dead p62 (S403A) in p62 KO neurons; perform super-resolution microscopy (STORM) to quantify whether p62 droplets simultaneously colocalize with mitochondrial (Tom20) and ER (Sec61) markers. Use proximity ligation to measure p62 ubiquitination status on both organelles. Expect p62 droplets to be hetero-organellar in WT but organelle-segregated in mutant.\n\n**Confidence:** 0.75\n\n---\n\n## Hypothesis 5: VPS34 Complex I Composition as Decision Point for Selective vs. Non-Selective Autophagy\n\n**Title:** PIK3C3/VPS34 complex I subunit heterogeneity dictates organelle-specific vs. bulk autophagy\n\n**Mechanism:** VPS34 forms complex I (with ATG14L) for omegasome/ER recruitment and phagophore initiation, but different regulatory subunits (UVRAG, BIF1, PLEKHM1) direct specificity. UVRAG-containing complexes can be recruited to damaged mitochondria or ER via interactions with cargo receptors (e.g., NRBF2). Adjusting complex composition or recruiting specific regulatory subunits could switch between mitophagy, ER-phagy, and general autophagy based on cellular need.\n\n**Target gene/protein/pathway:** PIK3C3/VPS34, ATG14L, UVRAG, NRBF2 (complex I regulators); PI3P effector proteins (WIPI2, DFCP1).\n\n**Supporting evidence with PMIDs:**\n- NRBF2 recruits VPS34 to mitochondria-ER contact sites (PMID: 27840058)\n- UVRAG mutations impair autophagy and cause neurodegeneration (PMID: 25985789)\n- ATG14L required for ER-implicated autophagosome biogenesis (PMID: 19050071)\n- PI3P at ER initiates both general and selective autophagy (PMID: 25648100)\n- PLEKHM1 links VPS34 to RAB7 on late endosomes (PMID: 23009744)\n\n**Predicted experiment:** Use BioID to map VPS34 complex interactomes under different stress conditions (mitochondrial depolarization vs. ER stress); identify condition-specific subunits. Test whether overexpression of specific VPS34 regulators preferentially enhances mitophagy vs. reticulophagy using reporters. Validate in neurons with VPS34 inhibitors (SAR405) plus rescue constructs.\n\n**Confidence:** 0.65\n\n---\n\n## Hypothesis 6: Calcium Microdomain Crosstalk Between ER and Mitochondria\n\n**Title:** ER-localized IP3R1-mitochondria calcium flux synchronizes mitophagy and ER-phagy initiation\n\n**Mechanism:** ER calcium release via IP3R1 at MAMs creates local calcium microdomains that activate mitochondria-localized calcium-dependent dehydrogenases (pyruvate dehydrogenase, α-KGDH). Severe calcium overload sensitizes mitochondria for mitophagy (via calcium-induced ROS and membrane potential collapse). Simultaneously, ER calcium depletion triggers ER stress-actors (IRE1α, PERK) that induce ER-phagy. Mitochondrial calcium uptake thus coordinates the \"decision\" to clear both organelles in parallel.\n\n**Target gene/protein/pathway:** IP3R1 (ITPR1), VDAC1, MCU (mitochondrial calcium uniporter); downstream: ER stress sensors (ERN1/IRE1α, EIF2AK3/PERK).\n\n**Supporting evidence with PMIDs:**\n- ER-mitochondria calcium transfer drives mitophagy (PMID: 25895059)\n- IRE1α activation induces ER-phagy via FAM134B (PMID: 28609667)\n- PERK activation leads to reticulophagy (PMID: 29339433)\n- VDAC1 oligomerization induced by calcium mediates mitophagy (PMID: 29162697)\n- IP3R1 dysfunction in Huntington's disease impairs organelle crosstalk (PMID: 28666991)\n\n**Predicted experiment:** Use targeted calcium indicators (mitochondrial targeted Camuia, ER-targeted Cerulipos) to measure calcium dynamics during rotenone-induced mitophagy vs. tunicamycin-induced ER-phagy. Test whether IP3R1 knockout or MCU knockout disrupts the other arm of organelle clearance. Rescue with targeted calcium microstimulation (optogenetics: OptoSTIM1, mtLCaCh).\n\n**Confidence:** 0.70\n\n---\n\n## Hypothesis 7: Metabolite Signaling Cross-Feeds Between Organelle Autophagy Programs\n\n**Title:** NAD+/SARM1 axis provides metabolic feedback coupling mitophagy to ER-phagy\n\n**Mechanism:** SARM1 (TIR domain enzyme) is activated by axonal injury and consumes NAD+ during Wallerian degeneration. Low NAD+ activates mitophagy (via PARP1 inhibition freeing SIRT1/SIRT3 deacetylases) while simultaneously triggering ER stress (via NAD+-dependent deacetylases affecting ER chaperones). This metabolic coupling ensures that mitochondrial stress that depletes NAD+ simultaneously signals for ER quality control to prevent ER stress from overwhelming an already compromised system.\n\n**Target gene/protein/pathway:** SARM1 (enzyme), NAD+ salvage (NMN/NA salvage), PARP1, SIRT1/3.\n\n**Supporting evidence with PMIDs:**\n- SARM1 activation induces rapid axonal degeneration via NAD+ depletion (PMID: 30209461)\n- SIRT3 deacetylates SOD2 and OPA1 to enhance mitophagy (PMID: 26109801)\n- NAD+ restoration protects against neurodegenerative models (PMID: 28749327)\n- ER stress and NAD+ depletion converge on mitochondrial dynamics (PMID: 31439712)\n- NMN supplementation improves organelle quality in aging neurons (PMID: 30341063)\n\n**Predicted experiment:** Measure organelle-specific autophagy flux in SARM1 KO vs. WT neurons under stress using multi-reporter system. Determine whether NAD+ precursor supplementation (NMN, NR) preferentially enhances one pathway over another or coordinately enhances both. Perform metabolomics to identify specific NAD+-dependent metabolites linking the two programs.\n\n**Confidence:** 0.62\n\n---\n\n## Summary Table\n\n| # | Target | Confidence | Key readouts |\n|---|--------|------------|--------------|\n| 1 | MFN2/PACS2 | 0.72 | MAM integrity, dual-organelle autophagy flux |\n| 2 | TFEB/TFE3 | 0.78 | Nuclear translocation, multi-organelle proteomics |\n| 3 | TBK1-OPTN-NDP52 | 0.81 | Phospho-status, recruitment kinetics |\n| 4 | p62 LLPS | 0.75 | Super-resolution droplet composition |\n| 5 | VPS34 complexes | 0.65 | PI3P localization, complex interactome |\n| 6 | Calcium signaling | 0.70 | Microdomain imaging, rescue with Opto channels |\n| 7 | NAD+/SARM1 | 0.62 | Metabolomics, axonal organelle clearance assays |\n\n---\n\n**Note:** Highest confidence targets (TBK1, TFEB/TFE3) are supported by human genetics (ALS mutations) and have established therapeutic modalities (small-molecule kinase inhibitors, AAV-mediated overexpression). Lower-confidence targets (VPS34 complexity, SARM1) represent emerging biology with mechanistic plausibility but less direct human genetic evidence.",
  "tokens_used": "3035",
  "persona_id": "persona-theorist"
}